{"cik":1630176,"taxonomy":"us-gaap","tag":"AmortizationOfIntangibleAssets","label":"Amortization of Intangible Assets","description":"The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.","entityName":"Healthy Extracts Inc.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":1579883,"accn":"0001520138-21-000444","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-01-01","end":"2020-03-31","val":1579883,"accn":"0001520138-21-000523","fy":2021,"fp":"Q2","form":"10-Q/A","filed":"2021-09-03","frame":"CY2020Q1"},{"start":"2020-01-01","end":"2020-06-30","val":1579883,"accn":"0001520138-20-000428","fy":2020,"fp":"Q2","form":"10-Q","filed":"2020-09-15"},{"start":"2020-01-01","end":"2020-06-30","val":1579883,"accn":"0001520138-21-000444","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-01-01","end":"2020-06-30","val":1579883,"accn":"0001520138-21-000523","fy":2021,"fp":"Q2","form":"10-Q/A","filed":"2021-09-03"},{"start":"2020-04-01","end":"2020-06-30","val":1579883,"accn":"0001520138-20-000428","fy":2020,"fp":"Q2","form":"10-Q","filed":"2020-09-15","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":-1579883,"accn":"0001520138-20-000516","fy":2020,"fp":"Q3","form":"10-Q","filed":"2020-10-29"},{"start":"2020-01-01","end":"2020-09-30","val":1579883,"accn":"0001520138-21-000728","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-01-01","end":"2020-12-31","val":1579883,"accn":"0001520138-21-000113","fy":2020,"fp":"FY","form":"10-K","filed":"2021-02-19"},{"start":"2020-01-01","end":"2020-12-31","val":1579883,"accn":"0001520138-22-000131","fy":2021,"fp":"FY","form":"10-K","filed":"2022-04-01","frame":"CY2020"}]}}